Skip to content
Triangle logo TriangleGet started
← Full study record

NCT05882890 · OUTCOME

Xerostomia Questionnaire

Does Craniosacraltherapy Combined With Exercises That Focuses om Respiration and Posture in the Upper Body Have an Effect on Xerostomia and Other Late Sequelae on People Who Has Been Suffering From Cancer in Mouth and Throat? · Source last updated 2026-06-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
score on a scale
Interval / dispersion
Full Range
Time frame
Baseline (before start of this study intervention, but at least two years after finishing treatment of cancer)

What was measured

A Danish questionnaire for following up on patients who have finished their cancer treatment in head and neck on a Danish hospital. It is used at least 3 months after treatment. The participants in this study has finished their treatment for cancer at least two years from enroling this study. VAS xerostomia scale0-10 (10 is worst) The remaining 14 questions were phrased "how much does \[question subject\] bother you:" (translated from Danish) not at all (1) - a little (2) - some (3) a lot (4) very much( 5) The final question(number 15) were: "How would you feel, if you had to live the rest of your life, with the symptoms you have now?:" enjoyable(1), very satisfied (2) neither satisfied ore unsatisfied(3), very unsatisfied(4), terrible(5) the sum of points from the 15 questions gives an overall score.

Analysis population: 11 participants entered the project. 1 participant was not analysed, because of to low score at the xerostomia vas-scale i baseline. The inclusioncriteria for entering the analysis phase of the project was a score at at least 4 n the xerostomia vas-scale

Groups in this outcome

Craniosacral Therapy Receivers

Please refer to baseline characteristics

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Craniosacral Therapy Receivers10

Reported measurements

VAS scale(0best -10 worst)
Values in score on a scale · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Craniosacral Therapy Receivers8Not reported610Not reported
Remaining 15 questions overall sum (15 worst-75 best)
Values in score on a scale · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Craniosacral Therapy Receivers46.4Not reported3065Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        6
        upper Limit
        10
        value
        8
    title
    VAS scale(0best -10 worst)
  2. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        30
        upper Limit
        65
        value
        46.4
    title
    Remaining 15 questions overall sum (15 worst-75 best)
denoms
  1. counts
    1. group Id
      OG000
      value
      10
    units
    Participants
description
A Danish questionnaire for following up on patients who have finished their cancer treatment in head and neck on a Danish hospital. It is used at least 3 months after treatment. The participants in this study has finished their treatment for cancer at least two years from enroling this study. VAS xerostomia scale0-10 (10 is worst) The remaining 14 questions were phrased "how much does \[question subject\] bother you:" (translated from Danish) not at all (1) - a little (2) - some (3) a lot (4) very much( 5) The final question(number 15) were: "How would you feel, if you had to live the rest of your life, with the symptoms you have now?:" enjoyable(1), very satisfied (2) neither satisfied ore unsatisfied(3), very unsatisfied(4), terrible(5) the sum of points from the 15 questions gives an overall score.
dispersion Type
Full Range
groups
  1. description
    Please refer to baseline characteristics
    id
    OG000
    title
    Craniosacral Therapy Receivers
param Type
MEAN
population Description
11 participants entered the project. 1 participant was not analysed, because of to low score at the xerostomia vas-scale i baseline. The inclusioncriteria for entering the analysis phase of the project was a score at at least 4 n the xerostomia vas-scale
reporting Status
POSTED
time Frame
Baseline (before start of this study intervention, but at least two years after finishing treatment of cancer)
title
Xerostomia Questionnaire
type
PRIMARY
unit Of Measure
score on a scale

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice